Medpace Holdings Operating Expenses 2014-2024 | MEDP

Medpace Holdings annual/quarterly operating expenses history and growth rate from 2014 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Medpace Holdings operating expenses for the quarter ending September 30, 2024 were $0.421B, a 3.3% increase year-over-year.
  • Medpace Holdings operating expenses for the twelve months ending September 30, 2024 were $1.662B, a 14.18% increase year-over-year.
  • Medpace Holdings annual operating expenses for 2023 were $1.549B, a 31.13% increase from 2022.
  • Medpace Holdings annual operating expenses for 2022 were $1.181B, a 25.17% increase from 2021.
  • Medpace Holdings annual operating expenses for 2021 were $0.944B, a 24.36% increase from 2020.
Medpace Holdings Annual Operating Expenses
(Millions of US $)
2023 $1,549
2022 $1,181
2021 $944
2020 $759
2019 $734
2018 $604
2017 $371
2016 $369
2015 $338
2014 $322
2013 $214
Medpace Holdings Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $421
2024-06-30 $423
2024-03-31 $407
2023-12-31 $411
2023-09-30 $408
2023-06-30 $382
2023-03-31 $348
2022-12-31 $318
2022-09-30 $306
2022-06-30 $291
2022-03-31 $267
2021-12-31 $254
2021-09-30 $242
2021-06-30 $236
2021-03-31 $212
2020-12-31 $205
2020-09-30 $184
2020-06-30 $175
2020-03-31 $195
2019-12-31 $194
2019-09-30 $186
2019-06-30 $179
2019-03-31 $175
2018-12-31 $161
2018-09-30 $152
2018-06-30 $147
2018-03-31 $143
2017-12-31 $97
2017-09-30 $93
2017-06-30 $90
2017-03-31 $91
2016-12-31 $95
2016-09-30 $95
2016-06-30 $92
2016-03-31 $87
2015-12-31
2015-09-30 $85
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $10.906B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $88.397B 10.97
Cencora (COR) United States $45.651B 17.16
Natera (NTRA) United States $23.104B 0.00
DiDi Global (DIDIY) China $21.969B 0.00
ICON (ICLR) Ireland $18.002B 16.03
Avantor (AVTR) United States $14.742B 22.10
Viatris (VTRS) United States $13.929B 4.29
Revvity (RVTY) United States $13.859B 24.08
BioMerieux (BMXMF) France $12.558B 0.00
CochLear (CHEOY) Australia $12.074B 0.00
Solventum (SOLV) United States $11.587B 0.00
Doximity (DOCS) United States $9.727B 57.25
EUROFINS SCIENT (ERFSF) Luxembourg $9.707B 0.00
Charles River Laboratories (CRL) United States $9.517B 18.39
HealthEquity (HQY) United States $8.694B 43.62
Sonic Healthcare (SKHHY) Australia $8.191B 0.00
Bausch + Lomb (BLCO) Canada $6.259B 29.11
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Organon (OGN) United States $4.082B 4.12
Sotera Health (SHC) United States $3.713B 19.86
BrightSpring Health Services (BTSG) United States $2.990B 63.59
Surgery Partners (SGRY) United States $2.625B 29.93
Concentras Parent (CON) United States $2.513B 0.00
GeneDx Holdings (WGS) United States $2.455B 0.00
Alignment Healthcare (ALHC) United States $2.277B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.006B 10.44
PACS (PACS) United States $1.955B 0.00
GoodRx Holdings (GDRX) United States $1.734B 45.50
Teladoc Health (TDOC) United States $1.699B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.658B 0.00
Progyny (PGNY) United States $1.597B 32.34
Establishment Labs Holdings (ESTA) $1.282B 0.00
CareDx (CDNA) United States $1.267B 0.00
Embecta (EMBC) United States $1.132B 7.92
Pediatrix Medical (MD) United States $1.068B 10.45
AMN Healthcare Services Inc (AMN) United States $1.023B 6.93
Agilon Health (AGL) United States $1.001B 0.00
QDM (QDMI) Hong Kong, SAR China $0.563B 14.73
SBC Medicals (SBC) United States $0.526B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
InnovAge Holding (INNV) United States $0.490B 0.00
DocGo (DCGO) United States $0.416B 15.69
Sonida Senior Living (SNDA) United States $0.409B 0.00
Enhabit (EHAB) United States $0.382B 33.04
COMPASS Pathways (CMPS) United Kingdom $0.242B 0.00
Sera Prognostics (SERA) United States $0.234B 0.00
MultiPlan (MPLN) United States $0.206B 0.00
LifeMD (LFMD) United States $0.205B 0.00
Performant Healthcare (PHLT) United States $0.197B 0.00
Beauty Health (SKIN) United States $0.192B 0.00
Biodesix (BDSX) United States $0.185B 0.00
Nutex Health (NUTX) United States $0.168B 0.00
So-Young (SY) China $0.104B 17.70
ModivCare (MODV) United States $0.094B 5.09
Ascend Wellness Holdings (AAWH) United States $0.092B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.049B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Co-Diagnostics (CODX) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.026B 0.00
Oncology Institute (TOI) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00